NASDAQ
1.19USD
+0.02 (+1.71%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
18.6M
P/E
—
EPS
—
Beta
0.55
52W range
0.62-3.63
Day range
1.15–1.23
Open
1.18
Prev close
1.17
Volume
60.4K
Avg volume
230.6K
Dividend
0.00
IPO
2002-11-28
https://www.globenewswire.com/news-release/2026/08/05/3339234/0/en/firefly-neuroscience-nasdaq-aiff-reports-291-increase-in-tms-center-customer-brain-scan-volumes.html · 8/5/2026+1.00
https://www.globenewswire.com/news-release/2026/07/28/3334152/0/en/Firefly-Neuroscience-NASDAQ-AIFF-and-Next-Health-Launch-Precision-Cognitive-Health-Initiative-as-FDA-Advisory-Committee-s-Recommendation-Backs-Broader-Access-to-Key-Neuroprotective.html · 7/28/2026+0.80
https://www.globenewswire.com/news-release/2026/06/02/3305043/0/en/Firefly-s-AI-Driven-Evoke-System-Powers-Discovery-of-Novel-Electrophysiological-Biomarker-for-PTSD.html · 6/2/2026+1.00
https://www.globenewswire.com/news-release/2026/04/13/3272407/0/en/With-Brain-Scan-Volume-Momentum-Accelerating-Firefly-Makes-History-by-Building-the-World-s-First-Known-200-000-Standardized-EEG-ERP-Depository.html · 4/13/2026
https://www.benzinga.com/news/health-care/26/03/51103409/whats-going-on-with-firefly-neuroscience-stock-on-friday · 3/6/2026+0.80
https://www.benzinga.com/news/health-care/26/03/51040662/firefly-neuroscience-skyrockets-brain-scan-breakthrough-fuels-rally · 3/4/2026+1.00
https://www.defenseworld.net/2026/01/10/firefly-neuroscience-nasdaqaiff-trading-down-1-8-heres-why.html · 1/10/2026-0.20
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
